Channel 42
Science is the answer to everything.

Two malaria papers out this week in the New England Journal of Medicine have seen some press coverage. Undoubtedly the more concerning discusses the parasite’s increasing resistance to artemisinin-based drugs in Cambodia – see Nature’s …

More: continued here

Proposals for compensating developing countries for curbing deforestation via the international carbon market risk neglecting biodiversity hotspots, two leading scientific organizations jointly declared today. …

More: continued here

Doug Sipp of the RIKEN Institute offers this additional information on yesterday’s post:This recent development is interesting for a number of reasons. One of the people arrested, Yuliy Baltaytis, has been working in stem cell tourism …

More: continued here

The timescale governing sea level rise response to temperature forcing is fitted as 3KYr. The ANDRILL data indicate WAIS collapse in the order of 1KYr. Can we reconcile these estimates? Although admittedly the subject paper does not …

More: continued here

I am an avid reader of your blog, and given the forest topic raised here, I can’t help but use this opportunity to share this slideshow which clarifies a lot of the misinformation about forests and climate: …

More: continued here

The space shuttle Endeavour is due to land in Florida today, touching down at 10:48 am, local time. Yesterday one of the thrusters that will help control the craft’s speed during descent failed during testing. NASA says, “This will not …

More: continued here

All Nature’s pandemic flu coverage is collected on our news special page. These regular updates on The Great Beyond round up the latest from other news sources around the globe. In an effort to encourage tourists to visit in the wake of …

More: continued here

Amid concerns about the rising cost of healthcare, a new study suggests the American public spent $33.9 billion of their health-dollars on unproven treatments in 2007. Research by the US National Center for Health Statistics shows this …

More: continued here

A member of a new class of antiretroviral drugs is safe and effective for patients beginning treatment against HIV, according to researchers who have completed a two-year multisite phase III clinical trial comparing it with standard antiretroviral drugs. The results are online and scheduled for publication in an upcoming issue of the Lancet.

More: continued here

The new anti-wrinkle facial filler Dysport, which could be used as an alternative to Botox, noticeably reduced frown lines between the eyes, according to users and independent reviewers in a study involving plastic surgeons at UT Southwestern Medical Center.

More: continued here